Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 6/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | GSK3B | P49841 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | PYGL | P06737 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | ATR | Q13535 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27393638 | 0.88 | AAK1 (0.48) | AAK1GSK3BMMP1KDM4ETGFBR1 | |
| SCHEMBL30953269 | 0.88 | AAK1 (0.48) | AAK1GSK3BMMP1KDM4ETGFBR1 | |
| SCHEMBL30953319 | 0.87 | AAK1 (0.55) | AAK1MAPK1MAPTGSK3BMMP1 | |
| SCHEMBL30953210 | 0.85 | AAK1 (0.46) | AAK1MAPK1ANO1IDO1MMP1 | |
| SCHEMBL30953439 | 0.85 | AAK1 (0.44) | AAK1MAPK1IDO1MMP1 | |
| SCHEMBL30953388 | 0.85 | AAK1 (0.46) | AAK1MAPK1MAPTGSK3BIDO1 | |
| SCHEMBL30953223 | 0.85 | AAK1 (0.44) | AAK1MAPK1MAPTGSK3B | |
| SCHEMBL30953417 | 0.85 | AAK1 (0.44) | AAK1MAPTGSK3B | |
| SCHEMBL30953416 | 0.82 | AAK1 (0.42) | AAK1MAPK1MAPTGSK3BALOX5 | |
| SCHEMBL30953508 | 0.82 | AAK1 (0.42) | AAK1MAPK1MAPTGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |